{
    "code": "02024134",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024134",
    "time": "2023-05-25 19:38:22",
    "許可證字號": "衛署藥輸字第024134號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/12\/02",
    "發證\/登錄日期": "93\/12\/02",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202413407",
    "中文品名": "欣流顆粒劑4毫克",
    "英文品名": "SINGULAIR ORAL GRANULES 4MG",
    "適應症": "適用於預防與長期治療成人及小兒的氣喘，包含預防日間及夜間氣喘症狀，及防止運動引起的支氣管收縮。用於先前已接受過其他抗過敏藥品，但療效不佳或無法耐受之成人及小兒的日間及夜間過敏性鼻炎(Allergic Rhinitis)。",
    "劑型": "156顆粒劑",
    "包裝": "1000公克以下鋁箔袋盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "MONTELUKAST SODIUM",
    "限制項目": "02輸　入",
    "申請商名稱": "荷蘭商歐嘉隆有限公司台灣分公司",
    "申請商地址": "臺北市信義區松仁路97號4樓",
    "主製造廠": [
        {
            "製造廠名稱": "Patheon Manufacturing Services LLC",
            "製造廠廠址": "5900 Martin Luther King Jr. Highway,Greenville,NC27834,USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "PT. Organon Pharma Indonesia Tbk.",
            "製造廠廠址": "JL. RAYA PANDAAN KM. 48, PANDAAN, PASURUAN, JAWA TIMUR , INDONESIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDONESIA",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "MERCK SHARP &amp; DOHME LLC.",
            "製造廠廠址": "4633 MERCK ROAD, WILSON, NORTH CAROLINA 27893, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "分裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200039110",
            "成分名稱": "MONTELUKAST SODIUM",
            "含量描述": "",
            "含量": "4.1600000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Singulair OG_-104-09-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024134&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "SINGULAIR_4, 5, 10mg_LEF_FDA upload_20230516-112-05-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024134&Seq=013&Type=9"
        },
        {
            "title": "SINGULAIR_10_4_5mg_LFT_TFDA upload-111-11-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024134&Seq=012&Type=9"
        },
        {
            "title": "20220719_Singulair_中文仿單擬稿_clean version-111-07-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024134&Seq=011&Type=9"
        },
        {
            "title": "Singulaor OG 4mg carton-108-03-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024134&Seq=007&Type=8"
        },
        {
            "title": "Singulair OG_4mg_CTN_20151012-104-10-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024134&Seq=006&Type=8"
        }
    ]
}